VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) Fundamental Analysis & Valuation

TSX-V:VPT • CA92281P2008

Current stock price

0.11 CAD
-0.01 (-4.35%)
Last:

This VPT.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. VPT.CA Profitability Analysis

1.1 Basic Checks

  • In the past year VPT has reported negative net income.
  • In the past year VPT has reported a negative cash flow from operations.
  • VPT had negative earnings in each of the past 5 years.
  • VPT had a negative operating cash flow in each of the past 5 years.
VPT.CA Yearly Net Income VS EBIT VS OCF VS FCFVPT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

  • VPT has a worse Return On Assets (-1076.66%) than 80.00% of its industry peers.
Industry RankSector Rank
ROA -1076.66%
ROE N/A
ROIC N/A
ROA(3y)-362.62%
ROA(5y)-271.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VPT.CA Yearly ROA, ROE, ROICVPT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

  • VPT has a worse Gross Margin (54.21%) than 60.00% of its industry peers.
  • VPT's Gross Margin has improved in the last couple of years.
  • VPT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y16.84%
VPT.CA Yearly Profit, Operating, Gross MarginsVPT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

0

2. VPT.CA Health Analysis

2.1 Basic Checks

  • VPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for VPT has been increased compared to 1 year ago.
  • Compared to 5 years ago, VPT has more shares outstanding
  • The debt/assets ratio for VPT is higher compared to a year ago.
VPT.CA Yearly Shares OutstandingVPT.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VPT.CA Yearly Total Debt VS Total AssetsVPT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • VPT has an Altman-Z score of -272.26. This is a bad value and indicates that VPT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of VPT (-272.26) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -272.26
ROIC/WACCN/A
WACC9.36%
VPT.CA Yearly LT Debt VS Equity VS FCFVPT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

  • A Current Ratio of 0.05 indicates that VPT may have some problems paying its short term obligations.
  • The Current ratio of VPT (0.05) is worse than 86.67% of its industry peers.
  • VPT has a Quick Ratio of 0.05. This is a bad value and indicates that VPT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VPT has a Quick ratio of 0.05. This is amonst the worse of the industry: VPT underperforms 86.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
VPT.CA Yearly Current Assets VS Current LiabilitesVPT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2

3. VPT.CA Growth Analysis

3.1 Past

  • VPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.15%, which is quite impressive.
  • VPT shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.55%.
  • The Revenue has been growing slightly by 3.28% on average over the past years.
EPS 1Y (TTM)23.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.04%
Revenue 1Y (TTM)28.55%
Revenue growth 3YN/A
Revenue growth 5Y3.28%
Sales Q2Q%61.71%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VPT.CA Yearly Revenue VS EstimatesVPT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2022 2023 2024 50K 100K 150K 200K 250K

0

4. VPT.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • VPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VPT.CA Price Earnings VS Forward Price EarningsVPT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VPT.CA Per share dataVPT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0 -0.01 -0.01 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. VPT.CA Dividend Analysis

5.1 Amount

  • No dividends for VPT!.
Industry RankSector Rank
Dividend Yield 0%

VPT.CA Fundamentals: All Metrics, Ratios and Statistics

VENTRIPOINT DIAGNOSTICS LTD

TSX-V:VPT (3/27/2026, 7:00:00 PM)

0.11

-0.01 (-4.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-28
Earnings (Next)04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.35%
Ins Owner ChangeN/A
Market Cap20.64M
Revenue(TTM)175.60K
Net Income(TTM)-4.06M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 117.55
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1076.66%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.21%
FCFM N/A
ROA(3y)-362.62%
ROA(5y)-271.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y16.84%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -272.26
F-Score4
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.55%
Revenue growth 3YN/A
Revenue growth 5Y3.28%
Sales Q2Q%61.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.54%
OCF growth 3YN/A
OCF growth 5YN/A

VENTRIPOINT DIAGNOSTICS LTD / VPT.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to VPT.CA.


What is the valuation status of VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to VENTRIPOINT DIAGNOSTICS LTD (VPT.CA). This can be considered as Overvalued.


What is the profitability of VPT stock?

VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) has a profitability rating of 1 / 10.


What is the financial health of VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) stock?

The financial health rating of VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) is 0 / 10.